← All companies ← AME Manual AMG → ← AIRS Health Care Providers & Services ARDT →
AMED, Amedisys
A healthcare-services business, paid to deliver or facilitate care.
The business
What it sells, where the money comes from, the kind of company it is.
The business in brief
What this business is and what moves its needle, from its own SEC filings.
- What moves the needle
- Gross margin has run about 43% and operating margin about 7.0% through the cycle, a solid spread between what it charges and what the product costs to make. Read this kind of business on volume, payer mix and reimbursement.
Every line is arithmetic on the company's filings, shown in full in the sections below.
The record
Ten years of arithmetic, read across the cycle.
The record, 2022–2024
realized figures from each filing · older years to the left| 2022’22 | 2023’23 | 2024’24 | TTMTTMJun 2025 | |
|---|---|---|---|---|
| Income statement | ||||
| $2.2B | $2.2B | $2.3B | $2.4B | RevenueRevenue |
| 43% | 44% | 43% | 43% | Gross marginGross mgn |
| 34% | 37% | 36% | 36% | SG&A / revenueSG&A/rev |
| $181M | $156M | $95M | $100M | Operating incomeOp. inc. |
| 8.1% | 7.0% | 4.0% | 4.1% | Operating marginOp. mgn |
| $119M | ($10M) | $43M | $86M | Net incomeNet inc. |
| 26% | — | 53% | 44% | Effective tax rateTax rate |
| Cash flow & returns | ||||
| $133M | $137M | $222M | $239M | Operating cash flowOp. cash |
| $25M | $24M | $26M | $27M | DepreciationDeprec. |
| ($27M) | $94M | $122M | $98M | Working capital & otherWC & other |
| $6M | $6M | $7M | $4M | CapexCapex |
| 0.3% | 0.3% | 0.3% | 0.2% | Capex / revenueCapex/rev |
| $127M | $132M | $215M | $235M | Owner earningsOwner earn. |
| 5.7% | 5.9% | 9.2% | 9.8% | Owner earnings marginOE mgn |
| $127M | $132M | $215M | $235M | Free cash flowFCF |
| 5.7% | 5.9% | 9.2% | 9.8% | Free cash flow marginFCF mgn |
| $72M | $350K | $0 | $0 | AcquisitionsAcquis. |
| $17M | $0 | $0 | — | BuybacksBuybacks |
| 9% | — | 4% | 4% | ROICROIC |
| 11% | -1% | 4% | 7% | Return on equityROE |
| 11% | −1% | 4% | 7% | Retained to equityRetained/eq |
| Balance sheet | ||||
| $41M | $126M | $303M | $337M | Cash & investmentsCash+inv |
| $297M | $313M | $296M | $296M | ReceivablesReceiv. |
| $44M | $28M | $40M | $30M | Accounts payablePayables |
| $253M | $285M | $256M | $266M | Operating working capitalOper. WC |
| $389M | $497M | $632M | $662M | Current assetsCur. assets |
| $356M | $474M | $514M | $488M | Current liabilitiesCur. liab. |
| 1.1× | 1.0× | 1.2× | 1.4× | Current ratioCurr. ratio |
| $1.3B | $1.2B | $1.2B | $1.2B | GoodwillGoodwill |
| $2.0B | $2.1B | $2.1B | $2.2B | Total assetsAssets |
| $435M | $398M | $377M | $363M | Total debtDebt |
| $394M | $272M | $74M | $26M | Net debt / (cash)Net debt |
| 8.1× | 5.0× | 3.1× | 3.6× | Interest coverageInt. cov. |
| $1.1B | $1.1B | $1.1B | $1.2B | Shareholders’ equityEquity |
| 0.7% | 1.3% | 1.3% | 1.2% | Stock comp / revenueSBC/rev |
| Per share | ||||
| 32.7M | 32.6M | 33.1M | 33.2M | Shares out (diluted)Shares |
| $68.09 | $68.60 | $71.05 | $72.29 | Revenue / shareRev/sh |
| $3.63 | $-0.30 | $1.31 | $2.58 | EPS (diluted)EPS |
| $3.89 | $4.04 | $6.51 | $7.07 | Owner earnings / shareOE/sh |
| $3.89 | $4.04 | $6.51 | $7.07 | Free cash flow / shareFCF/sh |
| $0.19 | $0.17 | $0.20 | $0.13 | Cap. spending / shareCapex/sh |
| $32.20 | $32.72 | $34.33 | $37.09 | Book value / shareBVPS |
The record, charted
FY2022–2024Each measure over its full record; the current point and the worst year marked.
Owner earnings vs. net income
Owner earningsNet incomeThe accountant's number, and the cash an owner can take; the gap is the tell.
Where the cash went
ReinvestBuybacksDividendsAcquisitionsRetainedEach year's operating cash, by what management did with it: the mix, and how it drifts.
Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.
In fiscal 2024 the business turned $43M of profit into $215M of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.
| FY2024 | FY2023 | FY2022 | |
|---|---|---|---|
| Reported net income | $43M | ($10M) | $119M |
| Depreciation & amortizationnon-cash charge added back | +$26M | +$24M | +$25M |
| Stock-based compensationreal costnon-cash, but a real cost | +$31M | +$29M | +$17M |
| Working capital & othertiming of cash in and out, other non-cash items | +$122M | +$94M | −$27M |
| Cash from operations | $222M | $137M | $133M |
| Capital expenditurecash put back in to keep running and to grow | −$7M | −$6M | −$6M |
| Owner earnings | $215M | $132M | $127M |
| Owner-earnings marginowner earnings ÷ revenue | 9% | 6% | 6% |
Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $31M), owner earnings is nearer $184M.
Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.
Quality & stewardship
Returns, the balance sheet, capital allocation, and pay.
Owner’s Scorecard
Will it survive?
- AdequateOperating income $95M ÷ interest expense $31M
What this means
Comfortable in a normal year, but below the margin of safety Graham looked for. Worth checking how stable the coverage has been across a full cycle.
- How heavy is the debt, net of cash? $74M · 0.8× operating profitModest net debtCash $303M − debt $377M
What this means
Netting $303M of cash and short-term investments against $377M of debt leaves $74M owed, about 0.8× a year's operating profit (4.0× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
- TightDSO 46 + DIO 0 − DPO 11 days
What this means
Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash. (Little or no inventory, a services / asset-light model, so the inventory leg is ~0.)
Is it a good business?
- Below averageNOPAT $47M ÷ invested capital $1.2B (debt + equity − cash)Industry peers: median 8%
What this means
The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.
- Solid through the cycle3-yr median margin, range 6%–9%; latest $215M = operating cash $222M − maintenance capex $7MIndustry peers: median 5%
What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 9% of revenue this year, a 6% median across 3 years. Treating stock comp as the real expense it is (less $31M of SBC) leaves $184M.
- Cash-backedCash from ops $222M ÷ net income $43M
What this means
How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.
How is the cash used?
- Reinvests most of itDividends + buybacks $0 ÷ Owner Earnings $215M
What this means
Of $215M Owner Earnings, $0 (0%) went back to shareholders, $0 dividends, $0 buybacks. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does.
- Investing or harvesting? 0.25×HarvestingCapex $7M ÷ depreciation $26M
What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.
Graham’s defensive tests · 1 of 3 met
Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.
- Adequate size PassRevenue ≥ $2B · $2.3B
What this means
Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.
- Strong liquidity MissCurrent ratio ≥ 2× · 1.23×
What this means
Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.
- Conservative debt MissDebt ≤ working capital · $377M vs $118M WC
What this means
Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.
- Moderate price —P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
What this means
Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $1.54/share (latest year $1.31), the averaged base the calculator's gate runs on, and book value is $34.50/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.
Does AI threaten the moat?
Moderate contestabilityAI is likely to reshape costs and some products here without clearly contesting or sparing the core moat; how the company itself frames it is the tell.
The question is whether a moat the record shows as durable outlasts a technology that lowers the cost of part of what the firm sells. The durability is read in the record above, the filing's own framing of AI beside it; the industry label decides nothing on its own.
Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.
All figures as filed; the source filing is linked above.
Current Position
as of the latest quarter, Jun 30, 2025Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.
- Cash & short-term investments$337M
- Receivables$296M
- Other current assets$29M
- Debt due within a year$37M
- Accounts payable$30M
- Other current liabilities$422M
From the company's latest filing.
Acquisitions & goodwill
from the balance sheet & the 3-year cash-flow recordGoodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.
None written down over the record; the goodwill is still carried at full cost. That is the deals holding their value on the books so far; whether they keep doing so is the test an owner watches, since the write-down, when it comes, is the admission the price was too high.
Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 3-year record, from the company's own filings.
Management, ownership & pay
read the proxy →From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.
| Fiscal year | Chief executive | Pay, as filed | “Actually paid” | Owner earnings |
|---|---|---|---|---|
| 2020 | Kusserow | $6.4M | $15.7M | — |
| 2021 | Kusserow | $8.3M | −$6.9M | — |
| 2022 | Gerard | $4.3M | $641k | $127M |
| 2022 | Kusserow | $4.1M | −$1.9M | $127M |
| 2023 | Ashworth | $16.7M | $4.1M | $132M |
| 2023 | Kusserow | $4.0M | $1.1M | $132M |
Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.
- Stock-based compensation$31M
The slice of the business handed to employees in shares this year, 1% of revenue, equal to 32% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.
Peers, Health Care Providers & Services
The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.
| Company | Revenue | Gross margin | Op. margin | ROIC | Owner earn. margin |
|---|---|---|---|---|---|
| OPCHOption Care Health Inc. | $5.6B | 22% | 4.6% | 9% | 4% |
| FTREFortrea Holdings Inc. | $2.7B | — | 1.1% | 1% | 5% |
| CHEChemed | $2.5B | 33% | 14.4% | 30% | 12% |
| AVAHAveanna Healthcare Holdings Inc. | $2.4B | — | 1.6% | 3% | -2% |
| AMEDAmedisys | $2.3B | 43% | 7.0% | 4% | 6% |
| CONConcentra Group Holdings Parent Inc. | $2.2B | — | 15.5% | 17% | 10% |
| PRVAPrivia Health Group | $2.1B | — | 1.2% | 8% | 5% |
| ADUSAddus HomeCare | $1.4B | 30% | 6.6% | 8% | 8% |
| Group median | — | 32% | 5.6% | 8% | 5% |
The price
What a price has to assume.
What the price implies
reverse-DCFType today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Amedisys has delivered.
—
9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.
Enter a price above to run it.
A dated snapshot of the price you typed, the assumptions you set, and what the page showed for them. A snapshot is never edited after it is saved. Your notebook is yours alone — the commitment states what is stored and what we will never do.
Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.
Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.
Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.
Owner earnings $235M on 33M shares outstanding, per the 10-Q cover, as of 2025-07-25; net debt $26M. The base is the latest year by default; Normalize values it on the through-cycle median owner-earnings margin (to avoid paying on a peak year). Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.
Manual order: ← AME its page in the Manual AMG →
Industry order: ← AIRS the Health Care Providers & Services chapter ARDT →